First Time Loading...
R

ReNeuron Group PLC
LSE:RENE

Watchlist Manager
ReNeuron Group PLC
LSE:RENE
Watchlist
Price: 3.375 GBX -2.17%
Updated: May 8, 2024

ReNeuron Group PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ReNeuron Group PLC
Revenue Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
R
ReNeuron Group PLC
LSE:RENE
Revenue
£250k
CAGR 3-Years
46%
CAGR 5-Years
38%
CAGR 10-Years
29%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Revenue
$1.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$41.6m
CAGR 3-Years
55%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
£249.4m
CAGR 3-Years
102%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Revenue
£673.1m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
6%

See Also

What is ReNeuron Group PLC's Revenue?
Revenue
250k GBP

Based on the financial report for Sep 30, 2023, ReNeuron Group PLC's Revenue amounts to 250k GBP.

What is ReNeuron Group PLC's Revenue growth rate?
Revenue CAGR 10Y
29%

Over the last year, the Revenue growth was -68%. The average annual Revenue growth rates for ReNeuron Group PLC have been 46% over the past three years , 38% over the past five years , and 29% over the past ten years .